Human Microbiome Market | Growth, Trends, and Forecast (2020

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

North America

Largest Market:

North America

CAGR:

22.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global human microbiome market is expected to show a CAGR of 22.60% during the forecast period. The key factors propelling the growth of this market are increasing incidence of lifestyle-related diseases and growing geriatric population.

The rising incidence of lifestyle-related diseases, globally, is a strong driver of the human microbiome market, as therapeutics may provide an alternative route to tackle significant healthcare challenges, such as obesity. The increasing occurrence of autoimmune disorders and antibiotic resistance are also important areas, which are in great need of fresh treatment approaches, and for which, microbiome therapies may have a significant impact over the next few years. With advancements in precision medicine, personalized nutrition is also playing a crucial role. Microbiome technologies strive for novel developments in the area. Cardiovascular diseases (CVD) continue to be the major cause of mortality, representing about 30% of all deaths, worldwide. Lifestyle-related diseases, like hypertension, diabetes mellitus, dyslipidaemia, and overweight/obesity, are the major risk factors for the development of CVD. With rapid economic development and increasing westernization of lifestyles in the past few decades, the prevalence of these diseases has reached alarming proportions in the recent years, which is expected to boost the growth of the human microbiome market.

Scope of the Report

The human microbiome is the aggregate of all microbiome that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjuctiva, and gastrointestinal tract.

By Application
		Therapeutics
		Diagnostics

By Disease
		Obesity
		Diabetes
		Autoimmune Disorder
		Cancer
		Gastrointestinal Disorders
		Central Nervous System Disorders
		Other Diseases

By Product
		Probiotics
		Prebiotics
		Symboitics
		Other Products

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Therapeutic Applications is Expected to hold the Highest Market Share

The microbiome-based products for therapeutics are still in the development phase. There are a number of organizations that are developing products across various disease areas in the human microbiome space. Companies have developed their own proprietary technology platforms and innovative approaches to microbiome-based treatment. The most common strategy deployed for a variety of products is the use of natural, live bacteria, either as a single agent or in a mixture form. Some companies are engineering bacteria and are programing them to take over certain physiologic functions to tackle rare disorders.

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to do Same in the Forecast Period

North America currently dominates the market for human microbiome due to the rising incidences of life style related diseases and autoimmune disorders in these regions. However, Asia Pacific is also expected to show a high growth rate due to improving research infrastructure in the region. In addition, several government associations are also supporting in the growth of human microbiome market in the region by providing funds and grants to increase research in the field of life science.

To understand geography trends, Download Sample Report.

Competitive Landscape

The human microbiome market is less competitive and there are several players that are coming up with new products. Companies, like Yakult, DuPont, Series Therapeutics, Second Genome, and Synthetic Biologics, hold substantial shares in the market.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Incidence of Lifestyle-related Diseases
  2. 4.2.2 Growing Geriatric Population
3. 4.3 Market Restraints
  1. 4.3.1 Lack of Comprehensive Research
  2. 4.3.2 Stringent Government Regulations
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Application
  1. 5.1.1 Therapeutics
  2. 5.1.2 Diagnostics
2. 5.2 By Disease
  1. 5.2.1 Obesity
  2. 5.2.2 Diabetes
  3. 5.2.3 Autoimmune Disorder
  4. 5.2.4 Cancer
  5. 5.2.5 Gastrointestinal Disorders
  6. 5.2.6 Central Nervous System Disorders
  7. 5.2.7 Other Diseases
3. 5.3 By Product
  1. 5.3.1 Probiotics
  2. 5.3.2 Prebiotics
  3. 5.3.3 Symboitics
  4. 5.3.4 Other Products
4. 5.4 Geography
  1. 5.4.1 North America
    1. 5.4.1.1 United States
    2. 5.4.1.2 Canada
    3. 5.4.1.3 Mexico
  2. 5.4.2 Europe
    1. 5.4.2.1 Germany
    2. 5.4.2.2 United Kingdom
    3. 5.4.2.3 France
    4. 5.4.2.4 Italy
    5. 5.4.2.5 Spain
    6. 5.4.2.6 Rest of Europe
  3. 5.4.3 Asia-Pacific
    1. 5.4.3.1 China
    2. 5.4.3.2 Japan
    3. 5.4.3.3 India
    4. 5.4.3.4 Australia
    5. 5.4.3.5 South Korea
    6. 5.4.3.6 Rest of Asia-Pacific
  4. 5.4.4 Middle East & Africa
    1. 5.4.4.1 GCC
    2. 5.4.4.2 South Africa
    3. 5.4.4.3 Rest of Middle East & Africa
  5. 5.4.5 South America
    1. 5.4.5.1 Brazil
    2. 5.4.5.2 Argentina
    3. 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Enterome Bioscience
  2. 6.1.2 Yakult Honsha Co., Ltd.
  3. 6.1.3 DuPont
  4. 6.1.4 Seres Therapeutics
  5. 6.1.5 Vithera Pharmaceuticals
  6. 6.1.6 Second Genome Inc.
  7. 6.1.7 Synthetic Biologics Inc.
  8. 6.1.8 Vedanta Biosciences Inc.
  9. 6.1.9 Osel Inc.
  10. 6.1.10 Synlogic Inc.

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments